EGFR and non-small cell lung carcinoma: NSCLC patients will most commonly be tested for mutations in epidermal growth factor receptors (EGFR), anaplastic lymphoma kinase (ALK) and Kirsten rat sarcoma viral oncogene homolog (KRAS).